CoreValve Scores $33M

CoreValve, an Irvine firm developing medical devices for percutaneous heart valve replacement, has raised $33M. Corevalve said today that the third round of funding was led by Maverick Capital, and also included existing investors Apax Partners, HealthCap, and Sofinnova Partners. CoreValve's technology is targeted at heart valve replacement and is based on a catheter techniques similar to angioplasty and stenting. More information »